Shanghai Hengrui Pharmaceutical Co., Ltd;Jiangsu Hengrui Medicine Co., Ltd.
发明人:
申请号：
EP18801322.1
公开号：
EP3626266A1
申请日:
2018.05.15
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention provides a PD-L1 antibody pharmaceutical composition and use thereof. In particular, the present invention provides a pharmaceutical composition comprising the PD-L1 antibody or an antigen-binding fragment thereof in a succinate buffer. In addition, the pharmaceutical composition may also contain a sugar and a nonionic surfactant.
